| Year |
Citation |
Score |
| 2023 |
Roux C, Goldsmith K, Cannon C. On the role of scarcity in marketing: Identifying research opportunities across the 5Ps. Journal of the Academy of Marketing Science. 1-6. PMID 37359269 DOI: 10.1007/s11747-023-00956-0 |
0.705 |
|
| 2022 |
Goldsmith K, Roux C, Tezer A, Cannon C. De-stigmatizing the "win-win:" making sustainable consumption sustainable. Current Opinion in Psychology. 46: 101336. PMID 35429922 DOI: 10.1016/j.copsyc.2022.101336 |
0.76 |
|
| 2020 |
Goldsmith K, Roux C, Cannon C. Understanding the relationship between resource scarcity and object attachment. Current Opinion in Psychology. 39: 26-30. PMID 32801105 DOI: 10.1016/J.Copsyc.2020.07.012 |
0.714 |
|
| 2020 |
Savary J, Goldsmith K. Unobserved altruism: How self-signaling motivations and social benefits shape willingness to donate. Journal of Experimental Psychology. Applied. PMID 31916807 DOI: 10.1037/Xap0000261 |
0.377 |
|
| 2020 |
Lamberton C, Goldsmith K. Ownership: A Perennial Prize or a Fading Goal? A Curation, Framework, and Agenda for Future Research Journal of Consumer Research. 47: 301-309. DOI: 10.1093/Jcr/Ucaa027 |
0.412 |
|
| 2020 |
Goldsmith K, Griskevicius V, Hamilton R. Scarcity And Consumer Decision Making:Is Scarcity A Mindset, A Threat, A Reference Point, Or A Journey? Journal of the Association For Consumer Research. DOI: 10.1086/710531 |
0.331 |
|
| 2020 |
Khan U, Goldsmith K, Dhar R. When Does Altruism Trump Self-Interest? The Moderating Role of Affect in Extrinsic Incentives Journal of the Association For Consumer Research. 5: 44-55. DOI: 10.1086/706512 |
0.454 |
|
| 2020 |
Goldsmith K, Roux C, Wilson AV. Can Thoughts of Having Less Ever Promote Prosocial Preferences? The Relationship between Scarcity, Construal Level, and Sustainable Product Adoption Journal of the Association For Consumer Research. 5: 70-82. DOI: 10.1086/706506 |
0.749 |
|
| 2019 |
Goldsmith K, Friedman EMS, Dhar R. You Don’t Blow Your Diet on Twinkies: Choice Processes When Choice Options Conflict with Incidental Goals Journal of the Association For Consumer Research. 4: 21-35. DOI: 10.1086/700840 |
0.397 |
|
| 2019 |
Cannon C, Goldsmith K, Roux C. A Self‐Regulatory Model of Resource Scarcity Journal of Consumer Psychology. 29: 104-127. DOI: 10.1002/Jcpy.1035 |
0.752 |
|
| 2018 |
Duke KE, Goldsmith K, Amir O. Is the Preference for Certainty Always So Certain? Journal of the Association For Consumer Research. 3: 63-80. DOI: 10.1086/695776 |
0.444 |
|
| 2018 |
Hamilton R, Thompson D, Bone S, Chaplin LN, Griskevicius V, Goldsmith K, Hill R, John DR, Mittal C, O’Guinn T, Piff P, Roux C, Shah A, Zhu M. The effects of scarcity on consumer decision journeys Journal of the Academy of Marketing Science. 47: 532-550. DOI: 10.1007/S11747-018-0604-7 |
0.746 |
|
| 2017 |
Goldsmith K, Roux C, Ma J. When Seeking the Best Brings Out the Worst in Consumers: Understanding the Relationship between a Maximizing Mindset and Immoral Behavior Journal of Consumer Psychology. 28: 293-309. DOI: 10.1002/Jcpy.1017 |
0.755 |
|
| 2016 |
Goldsmith K, Hershfield HE, Galoni C. What Two Wrongs Make Alright: Examining the Psychological Factors Underlying the Tendency to Temper Judgments of Intoxicated People Acr North American Advances. DOI: 10.2139/Ssrn.2628368 |
0.351 |
|
| 2016 |
Goldsmith K, Newman GE, Dhar R. Mental representation changes the evaluation of green product benefits Nature Climate Change. 6: 847-850. DOI: 10.1038/Nclimate3019 |
0.504 |
|
| 2015 |
Savary J, Goldsmith K, Dhar R. Giving against the Odds: When Tempting Alternatives Increase Willingness to Donate Journal of Marketing Research. 52: 27-38. DOI: 10.1509/Jmr.13.0244 |
0.457 |
|
| 2015 |
Roux C, Goldsmith K, Bonezzi A. On the Psychology of Scarcity: When Reminders of Resource Scarcity Promote Selfish (and Generous) Behavior Journal of Consumer Research. 42: 615-631. DOI: 10.1093/Jcr/Ucv048 |
0.751 |
|
| 2013 |
Goldsmith K, Dhar R. Negativity bias and task motivation: testing the effectiveness of positively versus negatively framed incentives. Journal of Experimental Psychology. Applied. 19: 358-66. PMID 24059820 DOI: 10.1037/A0034415 |
0.361 |
|
| 2013 |
Larson JS, Goldsmith K, Allen BJ. When a Reputation for Innovativeness Confers Negative Consequences for Brands Acr North American Advances. DOI: 10.2139/Ssrn.2313407 |
0.456 |
|
| 2012 |
Goldsmith K, Cho EK, Dhar R. When Guilt Begets Pleasure: The Positive Effect of a Negative Emotion Journal of Marketing Research. 49: 872-881. DOI: 10.1509/Jmr.09.0421 |
0.313 |
|
| 2012 |
Meyvis T, Goldsmith K, Dhar R. The Importance of the Context in Brand Extension: How Pictures and Comparisons Shift Consumers' Focus from Fit to Quality Journal of Marketing Research. 49: 206-217. DOI: 10.1509/Jmr.08.0060 |
0.327 |
|
| 2010 |
Goldsmith K, Amir O. Can Uncertainty Improve Promotions? Journal of Marketing Research. 47: 1070-1077. DOI: 10.1509/Jmkr.47.6.1070 |
0.428 |
|
| 2008 |
Huber J, Goldsmith K, Mogilner C. Reinforcement versus balance response in sequential choice Marketing Letters. 19: 229-239. DOI: 10.1007/S11002-008-9042-5 |
0.414 |
|
| 2005 |
Goldsmith M, Goldsmith K. Helping people achieve their goals Leader to Leader. 2006: 24-29. DOI: 10.1002/Ltl.162 |
0.356 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2023 |
Bagatell R, DuBois SG, Naranjo A, Belle J, Goldsmith KC, Park JR, Irwin MS. Children's Oncology Group's 2023 blueprint for research: Neuroblastoma. Pediatric Blood & Cancer. e30572. PMID 37458162 DOI: 10.1002/pbc.30572 |
0.135 |
|
| 2022 |
Ning L, Shim J, Tomov ML, Liu R, Mehta R, Mingee A, Hwang B, Jin L, Mantalaris A, Xu C, Mahmoudi M, Goldsmith KC, Serpooshan V. A 3D Bioprinted in vitro Model of Neuroblastoma Recapitulates Dynamic Tumor-Endothelial Cell Interactions Contributing to Solid Tumor Aggressive Behavior. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2200244. PMID 35644929 DOI: 10.1002/advs.202200244 |
0.111 |
|
| 2005 |
Goldsmith KC, Hogarty MD. Targeting programmed cell death pathways with experimental therapeutics: Opportunities in high-risk neuroblastoma Cancer Letters. 228: 133-141. PMID 15927359 DOI: 10.1016/j.canlet.2005.01.048 |
0.104 |
|
| 2021 |
Shim J, Goldsmith KC. A New Player in Neuroblastoma: YAP and Its Role in the Neuroblastoma Microenvironment. Cancers. 13. PMID 34572875 DOI: 10.3390/cancers13184650 |
0.102 |
|
| 2019 |
Esbenshade AJ, Kahalley LS, Baertschiger R, Dasgupta R, Goldsmith KC, Nathan PC, Harker-Murray P, Kitko CL, Kolb EA, Murphy ES, Muscal JA, Pierson CR, Reed D, Schore R, Unguru Y, et al. Mentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group. Pediatric Blood & Cancer. e27920. PMID 31309744 DOI: 10.1002/Pbc.27920 |
0.084 |
|
| 2020 |
Shim J, Lee JY, Jonus HC, Arnold A, Schnepp RW, Janssen KM, Maximov V, Goldsmith KC. YAP-mediated repression of HRK regulates tumor growth, therapy response, and survival under tumor environmental stress in neuroblastoma. Cancer Research. PMID 32900773 DOI: 10.1158/0008-5472.CAN-20-0025 |
0.077 |
|
| 2023 |
Mitchell SG, Basu GD, Eaton B, Goodman LJ, Goldsmith KC. Identification of a Novel Fusion with Targeted Therapeutic Implications in Locally Advanced Pediatric Cholangiocarcinoma: A Case Report. Case Reports in Oncology. 16: 249-255. PMID 37092120 DOI: 10.1159/000530164 |
0.068 |
|
| 2009 |
Lestini BJ, Goldsmith KC, Fluchel MN, Liu X, Chen NL, Goyal B, Pawel BR, Hogarty MD. Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists. Cancer Biology & Therapy. 8: 1587-95. PMID 19556859 |
0.058 |
|
| 2012 |
Goldsmith KC, Gross M, Peirce S, Luyindula D, Liu X, Vu A, Sliozberg M, Guo R, Zhao H, Reynolds CP, Hogarty MD. Mitochondrial Bcl-2 family dynamics define therapy response and resistance in neuroblastoma. Cancer Research. 72: 2565-77. PMID 22589275 DOI: 10.1158/0008-5472.Can-11-3603 |
0.057 |
|
| 2009 |
Goldsmith KC, Hogarty MD. Small-molecule BH3 mimetics to antagonize Bcl-2-homolog survival functions in cancer Current Opinion in Investigational Drugs. 10: 559-571. PMID 19513945 |
0.056 |
|
| 2018 |
Kumar R, Grams J, Chu DI, Crossman DK, Stahl R, Eipers P, Goldsmith K, Crowley M, Lefkowitz EJ, Morrow CD. New microbe genomic variants in patients fecal community following surgical disruption of the upper human gastrointestinal tract Human Microbiome Journal. 10: 37-42. DOI: 10.1016/J.Humic.2018.10.002 |
0.051 |
|
| 2015 |
Nalluri S, Peirce SK, Tanos R, Abdella HA, Karmali D, Hogarty MD, Goldsmith KC. EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma. Cancer Biology & Therapy. 16: 276-86. PMID 25756510 DOI: 10.1080/15384047.2014.1002333 |
0.049 |
|
| 2017 |
Ferris MJ, Danish H, Switchenko JM, Deng C, George BA, Goldsmith KC, Wasilewski KJ, Cash WT, Khan MK, Eaton BR, Esiashvili N. Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement. International Journal of Radiation Oncology, Biology, Physics. 97: 806-812. PMID 28244417 DOI: 10.1016/J.Ijrobp.2016.11.043 |
0.049 |
|
| 2019 |
Maximov V, Chen Z, Wei Y, Robinson MH, Herting CJ, Shanmugam NS, Rudneva VA, Goldsmith KC, MacDonald TJ, Northcott PA, Hambardzumyan D, Kenney AM. Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma. Nature Communications. 10: 2410. PMID 31160587 DOI: 10.1038/S41467-019-10458-9 |
0.049 |
|
| 2018 |
Dubois SG, Mosse YP, Fox E, Kudgus RA, Reid JM, McGovern R, Groshen S, Bagatell R, Maris JM, Twist CJ, Goldsmith KC, Granger M, Weiss B, Park JR, Macy ME, et al. Phase 2 Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30093449 DOI: 10.1158/1078-0432.CCR-18-1381 |
0.047 |
|
| 2018 |
Runco DV, Josephson CD, Raikar SS, Goldsmith KC, Lew G, Pauly M, Fasano RM. Hyperleukocytosis in infant acute leukemia: a role for manual exchange transfusion for leukoreduction. Transfusion. PMID 29399859 DOI: 10.1111/trf.14512 |
0.047 |
|
| 2019 |
Zoine JT, Knight KA, Fleischer LC, Sutton KS, Goldsmith KC, Doering CB, Spencer HT. Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model. Oncoimmunology. 8: 1593804. PMID 31413905 DOI: 10.1080/2162402X.2019.1593804 |
0.045 |
|
| 2016 |
Wetmore C, Daryani VM, Billups CA, Boyett JM, Leary S, Tanos R, Goldsmith KC, Stewart CF, Blaney SM, Gajjar A. Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021. Cancer Medicine. PMID 27109549 DOI: 10.1002/Cam4.713 |
0.045 |
|
| 2017 |
Marachelian A, Villablanca JG, Liu CW, Liu B, Goodarzian F, Lai HA, Shimada H, Tran HC, Parra JA, Gallego R, Bedrossian N, Young S, Czarnecki S, Kennedy R, Weiss B, ... Goldsmith KC, et al. Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28559462 DOI: 10.1158/1078-0432.Ccr-16-2647 |
0.043 |
|
| 2021 |
Vernooij L, Bate-Eya LT, Alles LK, Lee JY, Koopmans B, Jonus HC, Schubert NA, Schild L, Lelieveld D, Egan DA, Kerstjens M, Stam RW, Koster J, Goldsmith KC, Molenaar JJ, et al. High-throughput screening identifies idasanutlin as a resensitizing drug for venetoclax-resistant neuroblastoma cells. Molecular Cancer Therapeutics. PMID 33850004 DOI: 10.1158/1535-7163.MCT-20-0666 |
0.042 |
|
| 2023 |
Lee JY, Jonus HC, Sadanand A, Branella GM, Maximov V, Suttapitugsakul S, Schniederjan MJ, Shim J, Ho A, Parwani KK, Fedanov A, Pilgrim AA, Silva JA, Schnepp RW, Doering CB, ... ... Goldsmith KC, et al. Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma. Cell Reports. Medicine. 4: 101091. PMID 37343516 DOI: 10.1016/j.xcrm.2023.101091 |
0.042 |
|
| 2023 |
Berko ER, Witek GM, Matkar S, Petrova ZO, Wu MA, Smith CM, Daniels A, Kalna J, Kennedy A, Gostuski I, Casey C, Krytska K, Gerelus M, Pavlick D, Ghazarian S, ... ... Goldsmith KC, et al. Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma. Nature Communications. 14: 2601. PMID 37147298 DOI: 10.1038/s41467-023-38195-0 |
0.041 |
|
| 2022 |
Jonus HC, Burnham RE, Ho A, Pilgrim AA, Shim J, Doering CB, Spencer HT, Goldsmith KC. Dissecting the cellular components of γδ T cell expansions to optimize selection of potent cell therapy donors for neuroblastoma immunotherapy trials. Oncoimmunology. 11: 2057012. PMID 35371623 DOI: 10.1080/2162402X.2022.2057012 |
0.041 |
|
| 2015 |
Tanos R, Karmali D, Nalluri S, Goldsmith KC. Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma. Bmc Cancer. 16: 97. PMID 26874859 DOI: 10.1186/s12885-016-2129-0 |
0.039 |
|
| 2023 |
Goldsmith KC, Park JR, Kayser K, Malvar J, Chi YY, Groshen SG, Villablanca JG, Krytska K, Lai LM, Acharya PT, Goodarzian F, Pawel B, Shimada H, Ghazarian S, States L, et al. Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results. Nature Medicine. PMID 37012551 DOI: 10.1038/s41591-023-02297-5 |
0.039 |
|
| 2006 |
Teachey DT, Obzut DA, Axsom K, Choi JK, Goldsmith KC, Hall J, Hulitt J, Manno CS, Maris JM, Rhodin N, Sullivan KE, Brown VI, Grupp SA. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS). Blood. 108: 1965-71. PMID 16757690 DOI: 10.1182/Blood-2006-01-010124 |
0.038 |
|
| 2022 |
Summers RJ, Castellino SM, Porter CC, MacDonald TJ, Basu GD, Szelinger S, Bhasin MK, Cash T, Carter AB, Castellino RC, Fangusaro JR, Mitchell SG, Pauly MG, Pencheva B, Wechsler DS, ... ... Goldsmith KC, et al. Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care. Jco Precision Oncology. 6: e2100451. PMID 35544730 DOI: 10.1200/PO.21.00451 |
0.038 |
|
| 2018 |
Place AE, Goldsmith K, Bourquin JP, Loh ML, Gore L, Morgenstern DA, Sanzgiri Y, Hoffman D, Zhou Y, Ross JA, Prine B, Shebley M, McNamee M, Farazi T, Kim SY, et al. Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies. Future Oncology (London, England). PMID 29595064 DOI: 10.2217/Fon-2018-0121 |
0.038 |
|
| 2017 |
Kumar R, Yi N, Zhi D, Eipers P, Goldsmith KT, Dixon P, Crossman DK, Crowley MR, Lefkowitz EJ, Rodriguez JM, Morrow CD. Erratum: Author Correction: Identification of donor microbe species that colonize and persist long term in the recipient after fecal transplant for recurrent Clostridium difficile. Npj Biofilms and Microbiomes. 3: 29. PMID 29114399 DOI: 10.1038/s41522-017-0037-y |
0.037 |
|
| 2017 |
Kumar R, Yi N, Zhi D, Eipers P, Goldsmith KT, Dixon P, Crossman DK, Crowley MR, Lefkowitz EJ, Rodriguez JM, Morrow CD. Identification of donor microbe species that colonize and persist long term in the recipient after fecal transplant for recurrent Clostridium difficile. Npj Biofilms and Microbiomes. 3: 12. PMID 28649413 DOI: 10.1038/s41522-017-0020-7 |
0.032 |
|
| 2022 |
Çoku J, Booth DM, Skoda J, Pedrotty MC, Vogel J, Liu K, Vu A, Carpenter EL, Ye JC, Chen MA, Dunbar P, Scadden E, Yun TD, Nakamaru-Ogiso E, Area-Gomez E, ... ... Goldsmith KC, et al. Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance. The Embo Journal. e108272. PMID 35211994 DOI: 10.15252/embj.2021108272 |
0.03 |
|
| 2023 |
Pilgrim AA, Jonus HC, Ho A, Cole AC, Shim J, Goldsmith KC. The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of . Oncoimmunology. 12: 2240678. PMID 37554309 DOI: 10.1080/2162402X.2023.2240678 |
0.028 |
|
| 2019 |
Brown JT, Harik LR, Barbee MS, Esiashvili N, Badell ML, Goldsmith KC, Master VA, Bilen MA. Multidisciplinary Care of Adult Wilms' Tumor During Pregnancy: A Case Report and Review of the Literature. Clinical Genitourinary Cancer. PMID 31732475 DOI: 10.1016/j.clgc.2019.09.021 |
0.027 |
|
| 2021 |
DuBois SG, Granger MM, Groshen S, Tsao-Wei D, Ji L, Shamirian A, Czarnecki S, Goodarzian F, Berkovich R, Shimada H, Villablanca JG, Vo KT, Pinto N, Mosse YP, Maris JM, ... ... Goldsmith KC, et al. Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2100703. PMID 34270348 DOI: 10.1200/JCO.21.00703 |
0.025 |
|
| 2007 |
Kapp JA, Honjo K, Kapp LM, Goldsmith K, Bucy RP. Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 179: 2105-14. PMID 17675469 |
0.021 |
|
| 2019 |
Qayed M, Cash T, Tighiouart M, MacDonald TJ, Goldsmith KC, Tanos R, Kean L, Watkins B, Suessmuth Y, Wetmore C, Katzenstein HM. A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors. Pediatric Blood & Cancer. e28134. PMID 31876107 DOI: 10.1002/pbc.28134 |
0.02 |
|
| 2023 |
Cash T, Jonus HC, Tsvetkova M, Beumer JH, Sadanand A, Lee JY, Henry CJ, Aguilera D, Harvey RD, Goldsmith KC. A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors. Pediatric Blood & Cancer. e30405. PMID 37158620 DOI: 10.1002/pbc.30405 |
0.019 |
|
| 2016 |
Kumar R, Maynard CL, Eipers P, Goldsmith KT, Ptacek T, Grubbs JA, Dixon P, Howard D, Crossman DK, Crowley MR, Benjamin WH, Lefkowitz EJ, Weaver CT, Rodriguez JM, Morrow CD. Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile. Bmc Microbiology. 16: 5. PMID 26758906 DOI: 10.1186/S12866-015-0622-2 |
0.018 |
|
| 2004 |
Ilyas EN, Goldsmith K, Lintner R, Manders SM. Rhabdomyosarcoma arising in a giant congenital melanocytic nevus. Cutis. 73: 39-43. PMID 14964630 |
0.014 |
|
| 2017 |
Metts JL, Park SI, Soares BP, Fong C, Biegel JA, Goldsmith KC. Concurrent myeloid sarcoma, atypical teratoid/rhabdoid tumor, and hypereosinophilia in an infant with a germline SMARCB1 mutation. Pediatric Blood & Cancer. PMID 28111898 DOI: 10.1002/pbc.26460 |
0.01 |
|
| Hide low-probability matches. |